全文获取类型
收费全文 | 98146篇 |
免费 | 7130篇 |
国内免费 | 1808篇 |
专业分类
耳鼻咽喉 | 1059篇 |
儿科学 | 2436篇 |
妇产科学 | 1887篇 |
基础医学 | 11535篇 |
口腔科学 | 3717篇 |
临床医学 | 9261篇 |
内科学 | 21827篇 |
皮肤病学 | 2244篇 |
神经病学 | 6526篇 |
特种医学 | 2149篇 |
外国民族医学 | 7篇 |
外科学 | 12451篇 |
综合类 | 6388篇 |
现状与发展 | 2篇 |
一般理论 | 36篇 |
预防医学 | 8032篇 |
眼科学 | 2083篇 |
药学 | 7403篇 |
52篇 | |
中国医学 | 2442篇 |
肿瘤学 | 5547篇 |
出版年
2024年 | 167篇 |
2023年 | 900篇 |
2022年 | 2058篇 |
2021年 | 4078篇 |
2020年 | 2615篇 |
2019年 | 2983篇 |
2018年 | 3380篇 |
2017年 | 2706篇 |
2016年 | 2517篇 |
2015年 | 3345篇 |
2014年 | 4596篇 |
2013年 | 5444篇 |
2012年 | 8295篇 |
2011年 | 8615篇 |
2010年 | 5379篇 |
2009年 | 4635篇 |
2008年 | 6365篇 |
2007年 | 6398篇 |
2006年 | 5821篇 |
2005年 | 5461篇 |
2004年 | 4444篇 |
2003年 | 4212篇 |
2002年 | 3607篇 |
2001年 | 1039篇 |
2000年 | 991篇 |
1999年 | 860篇 |
1998年 | 651篇 |
1997年 | 544篇 |
1996年 | 480篇 |
1995年 | 397篇 |
1994年 | 337篇 |
1993年 | 255篇 |
1992年 | 394篇 |
1991年 | 317篇 |
1990年 | 259篇 |
1989年 | 235篇 |
1988年 | 217篇 |
1987年 | 190篇 |
1986年 | 182篇 |
1985年 | 181篇 |
1984年 | 145篇 |
1983年 | 130篇 |
1982年 | 108篇 |
1981年 | 129篇 |
1980年 | 110篇 |
1979年 | 98篇 |
1978年 | 74篇 |
1977年 | 94篇 |
1976年 | 69篇 |
1975年 | 59篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
111.
Carlos Ferrer Albiach Antonio Conde Moreno Marta Rodríguez Cordón Virginia Morillo Macías Ana Bouché Babiloni Inmaculada Beato Tortajada Ángel Sánchez Iglesias Alicia Francés Muñoz 《Clinical & translational oncology》2010,12(1):22-26
Hypoxia is related to poor prognosis because it is associated to chemo-and radioresistance. During recent years the evolution
of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation
therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring
tumour hypoxia. 相似文献
112.
113.
114.
Deborah P Jones Carlos A Camargo Frank E Speizer R Graham Barr 《The Journal of asthma》2007,44(4):291-295
The authors tested the hypothesis that short stature predicts adult-onset asthma independent of obesity among women in the Nurses' Health Study. Height, weight, and physician-diagnosed asthma were assessed with validated questionnaire items. Proportional hazard models adjusted separately for weight and body mass index. The rate of newly diagnosed asthma was 1.55 times greater in the shortest versus the tallest quintile after adjustment for weight (95% CI, 1.26-1.91). After adjustment for body mass index, the rate ratio was 1.16 (95% CI, 0.94-1.42). Short stature predicted adult-onset asthma in a large cohort of women, but this association was not independent of obesity. 相似文献
115.
Amalia Moreno Concepción Montón Yolanda Belmonte Miguel Gallego Xavier Pomares Jordi Real 《Archivos de bronconeumologia》2009,45(4):181-185
ObjectiveThe objective of this study was to assess the causes of death and risk factors for mortality in a cohort of patients with severe chronic obstructive pulmonary disease (COPD).Patients and methodsWe studied 203 patients with severe COPD (forced expiratory volume in 1 second [FEV1] <50%), who were attended in our respiratory department day hospital (2001-2006). Clinical variables were recorded on inclusion, and clinical course and causes of death were retrospectively reviewed.ResultsThe mean (SD) age of patients was 69 (8) years and the mean FEV1 was 30.8% (8.2%). One-hundred and nine patients died (53.7%); death was attributed to respiratory causes in 72 (80.9%), with COPD exacerbation being the most frequent specific cause within this category (48.3%). During follow-up, 18.7% required admission to the intensive care unit (ICU). Survival at 1, 3, and 5 years was 80%, 53%, and 26%, respectively. The multivariate analysis showed that mortality was associated with age, stage IV classification according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), cor pulmonale, and hospital admission during the year prior to inclusion. Need for admission to the ICU during follow-up was a factor independently associated with higher mortality.ConclusionsMortality in patients with severe COPD was high and exacerbation of the disease was one of the most frequent causes of death. Age, GOLD stage, cor pulmonale, prior admission to hospital, and need for admission to the ICU during follow-up were independent predictors of mortality. 相似文献
116.
117.
Estrella Fernández Fabrellas Luis Almenar Bonet Silvia Ponce Pérez José Antonio Moro López Rafael Blanquer Olivas Antonio Salvador Sanz 《Archivos de bronconeumologia》2009,45(4):173-180
Introduction and objectiveWhen sleep apnea-hypopnea syndrome (SAHS) and cardiovascular disease occur concurrently, prognosis is affected. Echocardiography can detect structural cardiac abnormalities but using this technique in all patients would place a heavy burden on resources. The objective of this study was to investigate whether the N-terminal fraction of brain natriuretic peptide (NT-proBNP) can be used as a marker for silent heart disease.Patients and methodsNT-proBNP concentration was measured in the 114 consecutive patients with SAHS who underwent echocardiography before starting treatment. Left and right ventricular systolic and diastolic function, as well as structural abnormalities, were studied. Correlations between NT-proBNP concentration and the abnormalities detected were investigated. A receiver operating characteristics (ROC) curve was plotted for NT-proBNP concentration and cardiac abnormalities.ResultsData for 98 patients were finally analyzed. NT-proBNP concentration was significantly correlated with ventricular septal thickness (r=0.63), posterior wall thickness (r=0.45), and left ventricular enddiastolic diameter (r=0.51) (P<.0001 for all correlations). The area under the ROC curve was significant (0.870; 95% confidence interval, 0.801-0.939; P<.0001). Assuming that specificity would be more useful for clinical practice, we calculated that NT-proBNP concentrations below 100 and 200 pg/mL could rule out structural abnormalities with a reliability of 90% and 100%, respectively.ConclusionsNT-proBNP concentration was strongly correlated with echocardiographic abnormalities and so could be a useful tool for identifying patients who should be referred to the cardiologist. 相似文献
118.
Enrique Cases Luis Seijo Carlos Disdier María José Lorenzo Rosa Cordovilla Francisca Sanchis Marimar Lacunza Gregoria Sevillano Fátima Benito-Sendín 《Archivos de bronconeumologia》2009,45(12):591-596
IntroductionTo analyse the effectiveness and safety of the indwelling pleural catheter in the management of recurrent malignant pleural effusion.Patients and methodsA prospective multicentre study was performed in 63 consecutive outpatients from four Spanish hospitals. A total of 43 men and 20 women were included, with a median age of 67 years. In seven of the cases treatment with pleurodesis had failed; in five other cases their lung was trapped; in another five cases after repeat therapeutic thoracocentesis, and the rest of them as a preference choice to pleurodesis. All patients had an indwelling pleural catheter inserted (PleurX®, Denver Biomedical).ResultsMost of patients (94.5%) reported an improvement in their respiratory symptoms (cough and dyspnoea) and their ability to function independently. Average length of the catheterisation was 45 days (6-222). Average amount of drained pleural effusion was 75 ml, with a frequency of drainage of between 3 and 4 times per week and once fortnightly. Spontaneous pleurodesis was achieved following 34.9% of procedures. No complications occurred during the insertion of the catheter. The post-catheterisation complications were empyema (3 cases), chest pain (2 cases), and tumour metastasis (3 cases).ConclusionsThe use of an indwelling pleural catheter is an effective palliative treatment in the outpatient management for patients suffering malignant pleural effusion. It is also a simple treatment that can be easily applied, does not require hospitalisation and can be easily managed by the patient at home, with a low rate of complications. 相似文献
119.